Plasma pancreatic polypeptide in the human neonate

Area of Science:

• Endocrinology
• Neonatal Physiology
• Gastroenterology

Background:

• Plasma pancreatic polypeptide (PP) plays a role in gastrointestinal function and metabolism.
• Understanding PP concentrations in neonates is crucial for assessing their physiological development and adaptation.
• Previous studies have established PP levels in adults, but data in newborns is limited.

Purpose of the Study:

• To investigate plasma pancreatic polypeptide (PP) concentrations in healthy term and preterm infants.
• To compare neonatal PP levels with those of adult subjects.
• To explore the response of PP to feeding in neonates.

Main Methods:

• Blood samples were collected from 197 healthy term and preterm infants at various postnatal ages.
• Plasma PP concentrations were measured using immunoassays.
• Data were analyzed to compare levels between infants and adults, and across different postnatal ages.

Main Results:

• At birth, plasma PP concentrations were lower in infants than in fasting adults.
• By the sixth postnatal day, basal PP levels in both term and preterm infants reached adult concentrations.
• In preterm infants, PP levels peaked around 13 days, exceeding adult levels by more than double, but did not show post-feeding elevations.

Conclusions:

• Neonatal plasma pancreatic polypeptide (PP) physiology differs significantly from that of adults.
• The lack of post-feeding PP response in neonates may indicate distinct regulatory mechanisms.
• These findings are potentially relevant to understanding infant adaptation to postnatal life and metabolic adjustments.